C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation

被引:93
作者
Cardozo, CP
Michaud, C
Ost, MC
Fliss, AE
Yang, E
Patterson, C
Hall, SJ
Caplan, AJ
机构
[1] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA
[3] Mt Sinai Sch Med, Carl C Icahn Inst Gene Therapy & Mol Med, New York, NY 10029 USA
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Carolina Cardiovasc Bio Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Carolina Cardiovasc Bio Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1016/S0003-9861(02)00680-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The androgen receptor (AR) is a member of the nuclear receptor superfamily that requires the action of molecular chaperones for folding and hormone binding. C-terminal Hsp-interacting protein (Chip) is a cochaperone that interacts with Hsp70 and Hsp90 molecular chaperones via a tetratricopeptide domain and inhibits chaperone-dependent protein folding in vitro. Chip also stimulates protein degradation by acting as an E3 ubiquitin ligase via a modified ring finger domain called a U box. We analyzed whether Chip affected AR levels using a transient transfection strategy. Chip overexpression led to a large decrease in AR steady state levels and increased levels of AR ubiquitinylation. However, Chip effects were not fully reversed by proteasome inhibitors, suggesting that mechanisms alternative to or in addition to proteasome-mediated degradation were involved. This hypothesis was supported by the finding that Chip overexpression reduced the rate of AR degradation, consistent with an effect on AR folding, perhaps leading to aggregation. The possibility that Chip affected AR folding was further supported by the finding that the effects of exogenous Chip were reproduced by a mutant lacking the U box. These results are discussed in terms of the role played by molecular chaperones in AR biogenesis. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 31 条
[1]
Bagatell R, 2001, CLIN CANCER RES, V7, P2076
[2]
Ballinger CA, 1999, MOL CELL BIOL, V19, P4535
[3]
INTERACTION OF HSP-70 WITH NEWLY SYNTHESIZED PROTEINS - IMPLICATIONS FOR PROTEIN FOLDING AND ASSEMBLY [J].
BECKMANN, RP ;
MIZZEN, LA ;
WELCH, WJ .
SCIENCE, 1990, 248 (4957) :850-854
[4]
HORMONE-DEPENDENT TRANSACTIVATION BY THE HUMAN ANDROGEN RECEPTOR IS REGULATED BY A DNAJ PROTEIN [J].
CAPLAN, AJ ;
LANGLEY, E ;
WILSON, EM ;
VIDAL, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (10) :5251-5257
[5]
Components of the bovine pituitary multicatalytic proteinase complex (proteasome) cleaving bonds after hydrophobic residues [J].
Cardozo, C ;
Michaud, C ;
Orlowski, M .
BIOCHEMISTRY, 1999, 38 (30) :9768-9777
[6]
The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins [J].
Connell, P ;
Ballinger, CA ;
Jiang, JH ;
Wu, YX ;
Thompson, LJ ;
Höhfeld, J ;
Patterson, C .
NATURE CELL BIOLOGY, 2001, 3 (01) :93-96
[7]
Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling [J].
Demand, J ;
Alberti, S ;
Patterson, C ;
Höhfeld, J .
CURRENT BIOLOGY, 2001, 11 (20) :1569-1577
[8]
Hsp90 regulates androgen receptor hormone binding affinity in vivo [J].
Fang, YF ;
Fliss, AE ;
Robins, DM ;
Caplan, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (45) :28697-28702
[9]
Kennedy disease [J].
Fischbeck, KH .
JOURNAL OF INHERITED METABOLIC DISEASE, 1997, 20 (02) :152-158
[10]
Differential in vivo regulation of steroid hormone receptor activation by Cdc37p [J].
Fliss, AE ;
Fang, YF ;
Boschelli, F ;
Caplan, AJ .
MOLECULAR BIOLOGY OF THE CELL, 1997, 8 (12) :2501-2509